Time to complete hematopoietic stem cell transplant and cellular therapy pharmacist tasks: real-world comparison to consensus recommendations
American Journal of Health-System Pharmacy · 11.11.2026
DOI: 10.1093/ajhp/zxag385 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Health-System Pharmacy, online erschienen am 11.11.2026. Verfasst von Shawn P Griffin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, Irvine, CA USA.
Abstract (Originalsprache)
Purpose
The Hematology/Oncology Pharmacy Association (HOPA) and the Hematology Oncology Practice Research Network within the American College of Clinical Pharmacy (ACCP) published consensus recommendations on how long the most common oncology pharmacist tasks take to complete. We set out to prospectively validate these recommendations specifically for hematopoietic stem cell transplantation and cellular therapy (HSCTCT) pharmacists.
Methods
A prospective, single-center, real-world study was conducted at an academic cancer center from August 1, 2024 to July 31, 2025. Documentation flowsheets within the electronic medical record were utilized to capture time required to complete 11 direct patient care tasks.
Results
A total of 4,708 tasks were documented. Eight of the eleven tasks evaluated were found to have a geometric mean completion time that fell below the consensus recommended range. 2,139 (45.4%) tasks were performed by experienced pharmacists compared to 2,569 (54.6%) that were completed by inexperienced pharmacists. Seven tasks had a statistically significant shorter geometric mean time to completion when performed by an experienced as compared to inexperienced HSCTCT pharmacist. A total of 4,523 tasks were classified into 2,931 (64.8%) performed in the inpatient setting and 1,592 (35.2%) performed in the ambulatory setting. Three tasks took longer to complete when performed in the ambulatory setting while one task took longer to complete in the inpatient setting. Conclusion(s) HSCTCT pharmacists completed 8 of 11 common direct patient care tasks in less time than consensus ranges. Generalized oncology time estimates may not describe HSCTCT practice well, and benchmarks warrant multicenter evaluation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, Irvine, CA USA.
- Department of Pharmacy, University of California Irvine Health, Orange, CA USA.
- University of Michigan College of Pharmacy, Ann Arbor, MI USA.
- Virginia Commonwealth University School of Pharmacy, Richmond, VA USA.
ORCID-Profile: Shawn P Griffin, Benjamin J Lee
Zitieren
APA
Griffin, S. P., Brown, B., Reddy, P., Doh, J., Sun, Y., Liu, J., Benitez, L. L., Hickey Zacholski, E., Joe, M. D., & Lee, B. J. (2026). Time to complete hematopoietic stem cell transplant and cellular therapy pharmacist tasks: real-world comparison to consensus recommendations. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxag385
Vancouver
Griffin SP, Brown B, Reddy P, Doh J, Sun Y, Liu J, et al. Time to complete hematopoietic stem cell transplant and cellular therapy pharmacist tasks: real-world comparison to consensus recommendations. American Journal of Health-System Pharmacy. 2026. doi:10.1093/ajhp/zxag385
BibTeX
@article{Griffin2026,
author = {Griffin, Shawn P and Brown, Brandon and Reddy, Prerana and Doh, Jean and Sun, Yujiao and Liu, Jenny and Benitez, Lydia L and Hickey Zacholski, Erin and Joe, Melanie D and Lee, Benjamin J},
title = {Time to complete hematopoietic stem cell transplant and cellular therapy pharmacist tasks: real-world comparison to consensus recommendations},
journal = {American Journal of Health-System Pharmacy},
year = {2026},
doi = {10.1093/ajhp/zxag385}
}
EUVIMED